• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重食管胃静脉曲张对肝硬化患者肝细胞癌肝切除的影响。

Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients.

作者信息

Liu Hsiao-Tien, Cheng Shao-Bin, Wu Cheng-Chung, Yeh Hong-Zen, Chang Chi-Sen, Wang John

机构信息

Department of Surgery, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung, 40705, Taiwan, Roc.

出版信息

World J Surg. 2015 Feb;39(2):461-8. doi: 10.1007/s00268-014-2811-9.

DOI:10.1007/s00268-014-2811-9
PMID:25338186
Abstract

BACKGROUND

The aim of the present study was to clarify both short-term and long-term results of patients with concomitant hepatocellular carcinoma (HCC) and high-risk oesophagogastric varices (OGV).

METHODS

This retrospective study identified 927 cirrhotic patients who underwent curative resection of HCC between 1995 and 2012 in single institution. Patients were separated into 3 groups (A, B, and C) according to general rules for recording endoscopic findings of oesophagogastric varices proposed in Japan in 1991. Groups A, B, and C consisted of patients without OGV (F0), patients with mild to moderate OGV (F1 to F2), and patients with high-risk OGV (F3 and/or red color sign), respectively. All patients in group C underwent prophylactic endoscopic variceal ligation/sclerotherapy. Post-operative complications, mortality, overall survival, and disease-free survival were compared among 3 groups.

RESULTS

No patient had post-operative variceal bleeding. Complication rates of Clavien-Dindo grade II to V in three groups were 13.6, 14.0, and 6.9 %, respectively (P > 0.05). Operative mortality, 5-year overall survival rate, and disease-free survival rate among the 3 groups were not significantly different (P > 0.05).

CONCLUSIONS

Prophylactic endoscopic variceal ligation/sclerotherapy effectively prevented from post-operative variceal bleeding in patients with high-risk OGV. Operative mortality, major morbidity, and survival of patients with high-risk OGV were similar to those of patients without OGV or those with mild OGV. Liver resection remains a feasible choice for cirrhotic patients with concomitant HCC and high-risk OGV.

摘要

背景

本研究旨在阐明合并肝细胞癌(HCC)和高危食管胃静脉曲张(OGV)患者的短期和长期结果。

方法

这项回顾性研究纳入了1995年至2012年在单一机构接受HCC根治性切除术的927例肝硬化患者。根据1991年日本提出的食管胃静脉曲张内镜检查结果记录通用规则,将患者分为3组(A、B和C组)。A、B和C组分别由无OGV(F0)、轻度至中度OGV(F1至F2)和高危OGV(F3和/或红色征)患者组成。C组所有患者均接受预防性内镜下静脉曲张结扎/硬化治疗。比较3组患者的术后并发症、死亡率、总生存率和无病生存率。

结果

无患者发生术后静脉曲张出血。三组患者Clavien-Dindo II至V级并发症发生率分别为13.6%、14.0%和6.9%(P>0.05)。三组患者的手术死亡率、5年总生存率和无病生存率差异无统计学意义(P>0.05)。

结论

预防性内镜下静脉曲张结扎/硬化治疗可有效预防高危OGV患者术后静脉曲张出血。高危OGV患者的手术死亡率、主要发病率和生存率与无OGV或轻度OGV患者相似。肝切除术仍然是合并HCC和高危OGV的肝硬化患者的可行选择。

相似文献

1
Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients.严重食管胃静脉曲张对肝硬化患者肝细胞癌肝切除的影响。
World J Surg. 2015 Feb;39(2):461-8. doi: 10.1007/s00268-014-2811-9.
2
Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.内镜治疗食管静脉曲张出血可改善Child C级肝硬化患者的预后。
J Gastroenterol Hepatol. 2006 Nov;21(11):1704-9. doi: 10.1111/j.1440-1746.2006.04267.x.
3
Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices.伴有食管静脉曲张的肝细胞癌的手术切除
World J Surg. 2015 Oct;39(10):2510-8. doi: 10.1007/s00268-015-3110-9.
4
Successful treatment of early hepatocellular carcinoma and concomitant esophageal varices.早期肝细胞癌及伴发食管静脉曲张的成功治疗。
World J Surg. 1993 May-Jun;17(3):398-402; discussion 402-3. doi: 10.1007/BF01658710.
5
Efficacy of prophylactic sclerotherapy in patients with hepatocellular carcinoma and varices negative for the red color sign.预防性硬化治疗对肝细胞癌合并红色征阴性静脉曲张患者的疗效
Gastrointest Endosc. 1997 Jun;45(6):498-502. doi: 10.1016/s0016-5107(97)70180-9.
6
Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma: prospective randomized study.预防性硬化疗法治疗食管静脉曲张合并不可切除肝细胞癌的优点:前瞻性随机研究
Dig Endosc. 2014 Mar;26(2):172-7. doi: 10.1111/den.12119. Epub 2013 May 8.
7
Is it a time to modify the BCLC guidelines in terms of the role of surgery?
World J Surg. 2015 Feb;39(2):469-70. doi: 10.1007/s00268-014-2915-2.
8
Advances in the treatment of hepatocellular carcinoma and concomitant esophageal varices.肝细胞癌及伴发食管静脉曲张的治疗进展
Hepatogastroenterology. 1990 Oct;37(5):461-4.
9
Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma.不可切除肝细胞癌患者静脉曲张出血的注射硬化疗法
Hepatogastroenterology. 2000 Nov-Dec;47(36):1680-4.
10
Successful surgical treatment for hepatocellular carcinoma and concomitant risky esophageal varices.肝细胞癌合并高危食管静脉曲张的成功手术治疗。
Hepatogastroenterology. 2005 Jul-Aug;52(64):1083-6.

引用本文的文献

1
Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.腹腔镜肝切除术治疗伴有临床显著门脉高压的肝细胞癌:系统评价和荟萃分析。
World J Surg Oncol. 2024 Jan 3;22(1):3. doi: 10.1186/s12957-023-03264-7.
2
Liver resection for hepatocellular carcinoma in oldest old patients.老年患者的肝细胞癌肝切除术。
World J Surg Oncol. 2019 Jan 3;17(1):1. doi: 10.1186/s12957-018-1541-0.
3
Liver resection for hepatocellular carcinoma in patients with hematological malignancies.

本文引用的文献

1
Coagulopathy in cirrhosis - the role of the platelet in hemostasis.肝硬化中的凝血功能障碍——血小板在止血中的作用
J Hepatol. 2013 Oct;59(4):889-90. doi: 10.1016/j.jhep.2013.03.040. Epub 2013 May 10.
2
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.在三级转诊中心,手术治疗肝细胞癌的有效适应证和结果概览:是否符合 EASL/AASLD 建议?:HCC 东西研究组的一项观察性研究。
Ann Surg. 2013 May;257(5):929-37. doi: 10.1097/SLA.0b013e31828329b8.
3
血液恶性肿瘤患者的肝细胞癌肝切除术。
World J Surg Oncol. 2017 Nov 2;15(1):194. doi: 10.1186/s12957-017-1260-y.
4
Management before hepatectomy for hepatocellular carcinoma with cirrhosis.伴有肝硬化的肝细胞癌肝切除术前的管理。
World J Hepatol. 2015 Sep 18;7(20):2292-302. doi: 10.4254/wjh.v7.i20.2292.
5
Is it a time to modify the BCLC guidelines in terms of the role of surgery?
World J Surg. 2015 Feb;39(2):469-70. doi: 10.1007/s00268-014-2915-2.
Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?
肝功能 Child-Pugh A 级肝硬化患者的肝细胞癌肝切除术:门静脉高压的临床证据是否是手术禁忌?
HPB (Oxford). 2013 Jan;15(1):78-84. doi: 10.1111/j.1477-2574.2012.00594.x. Epub 2012 Oct 24.
4
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
5
Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma.肝癌肝切除术前肝静脉压力梯度测量的价值。
Br J Surg. 2011 Dec;98(12):1752-8. doi: 10.1002/bjs.7672. Epub 2011 Oct 19.
6
General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?肝移植前新辅助治疗肝细胞癌的概述:必要性还是选择?
Liver Int. 2011 Sep;31(8):1081-9. doi: 10.1111/j.1478-3231.2011.02473.x.
7
Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience.连续改善肝细胞癌切除术的生存结果:20 年经验。
Ann Surg. 2011 Apr;253(4):745-58. doi: 10.1097/SLA.0b013e3182111195.
8
Hepatocellular carcinoma: current management and perspectives for the future.肝细胞癌:当前的治疗管理与未来展望。
Ann Surg. 2011 Mar;253(3):453-69. doi: 10.1097/SLA.0b013e31820d944f.
9
Is portal hypertension a contraindication to hepatic resection?门脉高压是否是肝切除术的禁忌证?
Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.
10
Treatment of concomitant gastric varices in patients with hepatocellular carcinoma at a single Japanese institute.日本一家机构对肝细胞癌患者合并胃静脉曲张的治疗
Hepatogastroenterology. 2009 May-Jun;56(91-92):857-60.